Correlation Between BP Plastics and Duopharma Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both BP Plastics and Duopharma Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BP Plastics and Duopharma Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BP Plastics Holding and Duopharma Biotech Bhd, you can compare the effects of market volatilities on BP Plastics and Duopharma Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BP Plastics with a short position of Duopharma Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of BP Plastics and Duopharma Biotech.

Diversification Opportunities for BP Plastics and Duopharma Biotech

-0.29
  Correlation Coefficient

Very good diversification

The 3 months correlation between 5100 and Duopharma is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding BP Plastics Holding and Duopharma Biotech Bhd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Duopharma Biotech Bhd and BP Plastics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BP Plastics Holding are associated (or correlated) with Duopharma Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Duopharma Biotech Bhd has no effect on the direction of BP Plastics i.e., BP Plastics and Duopharma Biotech go up and down completely randomly.

Pair Corralation between BP Plastics and Duopharma Biotech

Assuming the 90 days trading horizon BP Plastics Holding is expected to under-perform the Duopharma Biotech. But the stock apears to be less risky and, when comparing its historical volatility, BP Plastics Holding is 1.08 times less risky than Duopharma Biotech. The stock trades about -0.05 of its potential returns per unit of risk. The Duopharma Biotech Bhd is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  121.00  in Duopharma Biotech Bhd on September 1, 2024 and sell it today you would earn a total of  2.00  from holding Duopharma Biotech Bhd or generate 1.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

BP Plastics Holding  vs.  Duopharma Biotech Bhd

 Performance 
       Timeline  
BP Plastics Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days BP Plastics Holding has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, BP Plastics is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.
Duopharma Biotech Bhd 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Duopharma Biotech Bhd are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite quite persistent basic indicators, Duopharma Biotech is not utilizing all of its potentials. The latest stock price mess, may contribute to short-term losses for the institutional investors.

BP Plastics and Duopharma Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with BP Plastics and Duopharma Biotech

The main advantage of trading using opposite BP Plastics and Duopharma Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BP Plastics position performs unexpectedly, Duopharma Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Duopharma Biotech will offset losses from the drop in Duopharma Biotech's long position.
The idea behind BP Plastics Holding and Duopharma Biotech Bhd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Commodity Directory
Find actively traded commodities issued by global exchanges
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Global Correlations
Find global opportunities by holding instruments from different markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device